Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Lasa Supergenerics has informed that the Company has been granted patent, by Controller of Patents, for an invention ‘PROCESSES FOR PREPARATION AND PURIFICATION OF 5-CHLORO-2-NITROANILINE’ on 11th Day of September, 2024 for a term of 20 years effective from 19th Day of June, 2020, in accordance with the provisions of Patents Act, 1970. The above information will also be made available on the Company's website: www.lasalabs.com.
The above information is a part of company’s filings submitted to BSE.
